Jury Awards More Than $80.26M In Glyphosate Cancer Trial Against Monsanto

(March 28, 2019, 8:22 AM EDT) -- SAN FRANCISCO — A jury in California on March 27 awarded a cancer victim $80,267,644.10 in the federal bellwether glyphosate trial, finding that the herbicide Roundup lacked sufficient warnings concerning the risk of cancer and that Monsanto Co. was negligent in failing to warn of that risk.  Monsanto’s parent company, Bayer AG, said it will appeal (In re:  Roundup Products Liability Litigation, MDL No. 2741, N.D. Calif.)....

Attached Documents

Related Sections